Innovation Pharmaceuticals Inc (IPIX)

[frrol]

Hah! Confirmation bias at its most humorous.
In all seriousness, it's pretty apparent there is a billing dispute and likely a contract performance dispute (missed recruitment milestones I'd bet) that started it, and now the CRO is saying "no more payables, we want payment if you want your data." And Aspire is balking at coughing up more capital.

Too much at stake to throw in the towel; management will certainly do what it can to get the P data and stay afloat long enough for this B negotiation to conclude (one way or the other). But until the market knows this for sure, the share price will reflect the uncertainty.